...s, cells in your eye are transmitting information ...ies work just as hard to keep that brain alive. Ev...e body -- depends on an internal process called en...nd information healthy and strong. , It,s an incre...at Weill Medical College of Cornell University in ...
... packaging. How nature wraps and tags genes determ...researchers from Harvard and the Massachusetts Ins...t, most detailed study to date of the protein stru...dings reveal surprising and previously unknown spe...ment of the human body and in diseases such as can...
...t growing older are as,inevitable and obvious as “...lain the precise cause of this usually unwelcome t... site of the journal Science,researchers from Dan...Boston say they have found the cellular cause of g...ignant melanoma, the potentially deadly,skin cance...
Other Biology News:Weill Cornell Research Reveals Secrets Of Trafficking Within Cells 2Weill Cornell Research Reveals Secrets Of Trafficking Within Cells 3Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 2Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease 3Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 2Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 3(Date:11/18/2009)..., NEW YORK, Nov. 18 Reportlinker...s available in its catalogue. ,, Biotechnolog... http://www.reportlinker.com/p0164375/Biotechnolog...source=prnewswire&utm_medium=pr&utm_campai...gy are complex chemical compounds used in a range ...
(Date:11/18/2009)... Promega Corporation and SwitchGear G... DNA-protein interactions. , ...Promega Corporation and SwitchGear Genomics announ...nteractions. Results of a study using the HaloCHIP... demonstrate the ability to correlate DNA binding ...
(Date:11/18/2009)...VT-111 significantly reduces key cardiac enzymes a... presented at American Heart Association 2009 Scie...wire/ - Viron Therapeutics Inc., a biotechnology c...ting protein therapeutics derived from pathogens, ...rial evaluating VT-111 (Serp-1), an anti-inflammat...
(Date:11/18/2009)..., BALTIMORE, Nov. 18 Ch...CSBR), an oncology drug development company with a...ting the development and enhancing the value of on...ng agreement with Yale University and Southern Res...or cancer treatment. Scientists from Yale and Sou...
Breaking Biology Technology:Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 2Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 3Champions Biotechnology Enters into Licensing Agreement with Yale University and Southern Research Institute for the Repurposing of Bithionol for Oncology 4...SEY CITY, New Jersey, October 29, Rosetta Genomics... of microRNA-based diagnostics, announced today it...al Healthcare Conference,taking place November 3-4...ty., About MicroRNA, MicroRNAs (miRNAs) are rece...hat act as master regulators and have the potentia...
.... 29 Osteotech, Inc.,(Nasdaq: OSTE ), a leader i...enerative healing, announced today that it has rec... and Drug Administration ("FDA") for its next,gene...) clearance for this,material as a bone graft subs...spine, pelvis and extremities., Sam Owusu-Akyaw, ...
...Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announ... at the Oppenheimer 19th Annual Healthcare Confere...5:40 a.m. Pacific Time) at the,Waldorf=Astoria Hot...ce,President, Finance and Chief Financial Officer,...y, including its clinical development and discover...
Other Biology Technology:Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Osteotech Receives FDA Clearance for its Next Generation Grafting Material 2Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference 3Mouse Anti-Human PPP2R2C Monoclonal Antibody, Unconjugated, Clone 6D1 from Novus Biologicals
96-well 0.2 ml PCR Plate Caps, 300 from Bio-Rad
PROTEIN G PLUS AGAROSE from Pierce Biotechnology, Inc.
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: